Milliman: Even Split Between Seniors Hurt, Helped By Part D Proposal

By Gabrielle Wanneh / March 10, 2022 at 2:28 PM

CMS’ proposal to make Part D plans subtract pharmacy fees from drug prices at the point-of-sale would increase drug costs for one-third of beneficiaries and decrease costs for another third of beneficiaries, according to a study by Milliman that was paid for by the Pharmaceutical Care Management Association.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.